[1]
2017. Open-Label Study (ARIDO) Evaluating Long-Term Safety of Topical Glycopyrronium Tosylate (GT) in Patients with Axillary Hyperhidrosis. SKIN The Journal of Cutaneous Medicine. 1, 3.1 (Oct. 2017), s95. DOI:https://doi.org/10.25251/skin.1.supp.94.